Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Arian Lasocki

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
Journal of Medical Imaging and Radiation Oncology|February 27, 2023
Radiation necrosis and therapeutic outcomes in patients treated with linear accelerator-based hypofractionated stereotactic radiosurgery for intact intracranial metastasesQichen Zhang, Daniel Hamilton, Paul Conway, et al.
Neuro-Oncology|September 10, 2019
High-resolution MRI demonstrates that more than 90% of small intracranial melanoma metastases develop in close relationship to the leptomeningesArian Lasocki, Chloe Khoo, Peter K H Lau, et al.
Journal of Medical Imaging and Radiation Oncology|May 23, 2022
Machine learning imaging applications in the differentiation of true tumour progression from treatment-related effects in brain tumours: A systematic review and meta-analysisAbhishta Bhandari, Ravi Marwah, Justin Smith, et al.
Leukemia & Lymphoma|May 16, 2022
Neuroimaging findings in immune effector cell associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapyAdam H Lapidus, Mary Ann Anderson, Simon J Harrison, et al.
Health Science Reports|April 3, 2019
Bevacizumab as a steroid-sparing agent during immunotherapy for melanoma brain metastases: A case seriesPatricia D Banks, Arian Lasocki, Peter K H Lau, et al.
Neuroradiology|June 14, 2023
Correlating MRI features with additional genetic markers and patient survival in histological grade 2-3 IDH-mutant astrocytomasArian Lasocki, Michael E Buckland, Tahlia Molinaro, et al.
Neuroradiology|May 23, 2022
Conventional MRI features can predict the molecular subtype of adult grade 2-3 intracranial diffuse gliomasArian Lasocki, Michael E Buckland, Katharine J Drummond, et al.
Neuro-Oncology|July 21, 2025
Point/counterpoint: The role of re-resection in recurrent glioblastomaJacob S Young, Mitchel S Berger, Arian Lasocki, et al.
Asia-Pacific Journal of Clinical Oncology|March 26, 2026
Management of Adult Patients With Isocitrate Dehydrogenase-Mutant Gliomas in Australia: An Expert Position Statement From the Cooperative Trials Group for Neuro-OncologyMark B Pinkham, Hao-Wen Sim, Rosalind L Jeffree, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 22, 2023
Favourable outcomes with an initial active surveillance strategy for asymptomatic radiation-induced meningiomas in long-term survivors of paediatric and young adult malignanciesMary Xu, Arian Lasocki, Mathias Bressel, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
Journal of Medical Imaging and Radiation Oncology|February 27, 2023
Radiation necrosis and therapeutic outcomes in patients treated with linear accelerator-based hypofractionated stereotactic radiosurgery for intact intracranial metastasesQichen Zhang, Daniel Hamilton, Paul Conway, et al.
Neuro-Oncology|September 10, 2019
High-resolution MRI demonstrates that more than 90% of small intracranial melanoma metastases develop in close relationship to the leptomeningesArian Lasocki, Chloe Khoo, Peter K H Lau, et al.
Journal of Medical Imaging and Radiation Oncology|May 23, 2022
Machine learning imaging applications in the differentiation of true tumour progression from treatment-related effects in brain tumours: A systematic review and meta-analysisAbhishta Bhandari, Ravi Marwah, Justin Smith, et al.
Leukemia & Lymphoma|May 16, 2022
Neuroimaging findings in immune effector cell associated neurotoxicity syndrome after chimeric antigen receptor T-cell therapyAdam H Lapidus, Mary Ann Anderson, Simon J Harrison, et al.
Health Science Reports|April 3, 2019
Bevacizumab as a steroid-sparing agent during immunotherapy for melanoma brain metastases: A case seriesPatricia D Banks, Arian Lasocki, Peter K H Lau, et al.
Neuroradiology|June 14, 2023
Correlating MRI features with additional genetic markers and patient survival in histological grade 2-3 IDH-mutant astrocytomasArian Lasocki, Michael E Buckland, Tahlia Molinaro, et al.
Neuroradiology|May 23, 2022
Conventional MRI features can predict the molecular subtype of adult grade 2-3 intracranial diffuse gliomasArian Lasocki, Michael E Buckland, Katharine J Drummond, et al.
Neuro-Oncology|July 21, 2025
Point/counterpoint: The role of re-resection in recurrent glioblastomaJacob S Young, Mitchel S Berger, Arian Lasocki, et al.
Asia-Pacific Journal of Clinical Oncology|March 26, 2026
Management of Adult Patients With Isocitrate Dehydrogenase-Mutant Gliomas in Australia: An Expert Position Statement From the Cooperative Trials Group for Neuro-OncologyMark B Pinkham, Hao-Wen Sim, Rosalind L Jeffree, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|September 22, 2023
Favourable outcomes with an initial active surveillance strategy for asymptomatic radiation-induced meningiomas in long-term survivors of paediatric and young adult malignanciesMary Xu, Arian Lasocki, Mathias Bressel, et al.
Pageof 6